Facilitating Neuroplastic Changes of Acute Stroke Survivors - Trial NCT06404268
Access comprehensive clinical trial information for NCT06404268 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by University of Maryland, Baltimore and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Maryland, Baltimore
Timeline & Enrollment
Phase 1/2
May 01, 2024
Apr 01, 2029
Primary Outcome
Fugl-Meyer Lower Extremity (FMLE)
Summary
This project will develop a wearable rehabilitation robot suitable for in-bed acute stage
 rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory
 rehabilitation early in the acute stage post-stroke including patients who are paralyzed with
 no motor output. The early acute stroke rehabilitation device will be evaluated in this
 clinical trial.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06404268
Device Trial